Search

John D Yasko Jr

Examiner (ID: 12123)

Most Active Art Unit
3306
Art Unit(s)
3764, 3734, 2899, 3306, 763, 3763, 3742, 3305
Total Applications
3405
Issued Applications
2977
Pending Applications
169
Abandoned Applications
259

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16961437 [patent_doc_number] => 20210212936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => PARENTERAL NUTRITION FORMULATION [patent_app_type] => utility [patent_app_number] => 17/059932 [patent_app_country] => US [patent_app_date] => 2018-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14424 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059932 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/059932
PARENTERAL NUTRITION FORMULATION May 31, 2018 Pending
Array ( [id] => 15683569 [patent_doc_number] => 20200096448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => METHOD AND DEVICE FOR PROVIDING A CELL LINE HAVING A DESIRED TARGET PROTEIN EXPRESSION [patent_app_type] => utility [patent_app_number] => 16/609146 [patent_app_country] => US [patent_app_date] => 2018-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4450 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609146 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609146
METHOD AND DEVICE FOR PROVIDING A CELL LINE HAVING A DESIRED TARGET PROTEIN EXPRESSION Apr 5, 2018 Abandoned
Array ( [id] => 16437380 [patent_doc_number] => 20200354706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => NOVEL RECOMBINANT BOTULINUM TOXIN WITH INCREASED DURATION OF EFFECT [patent_app_type] => utility [patent_app_number] => 16/760377 [patent_app_country] => US [patent_app_date] => 2017-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760377 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/760377
NOVEL RECOMBINANT BOTULINUM TOXIN WITH INCREASED DURATION OF EFFECT Nov 21, 2017 Pending
Menu